Optiray 320 Interactions
There are 149 drugs known to interact with Optiray 320 (ioversol), along with 7 disease interactions. Of the total drug interactions, 86 are major, and 63 are moderate.
- View all 149 medications that may interact with Optiray 320
- View Optiray 320 disease interactions (7)
Most frequently checked interactions
View interaction reports for Optiray 320 (ioversol) and the medicines listed below.
- acyclovir
- Adderall (amphetamine / dextroamphetamine)
- Adrenalin (epinephrine)
- Advil (ibuprofen)
- Akineton (biperiden)
- albuterol
- Aldactone (spironolactone)
- Aldomet (methyldopa)
- alfentanil
- Align (bifidobacterium infantis)
- Alive Women's Energy (multivitamin with minerals)
- amlodipine
- Amoxil (amoxicillin)
- azithromycin
- calcium carbonate
- codeine
- ferrous sulfate
- hydrochlorothiazide
- hydroxyzine
- Lasix (furosemide)
- metoprolol
- omeprazole
- ondansetron
- oxcarbazepine
- pantoprazole
- Paracetamol (acetaminophen)
- scopolamine
- Trental (pentoxifylline)
- Vitamin C (ascorbic acid)
- Zyrtec (cetirizine)
Optiray 320 disease interactions
There are 7 disease interactions with Optiray 320 (ioversol) which include:
- hyperthyroidism
- pheochromocytoma
- sickle cell disease
- myasthenia gravis
- asthma/allergies
- acute renal failure
- cardiovascular disease
Report options
QR code containing a link to this page
More about Optiray 320 (ioversol)
- Optiray 320 consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: non-ionic iodinated contrast media
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.